Evofem Biosciences Announces Closing of $50 Million Public Offering
SAN DIEGO, May 21, 2021 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced the closing of its previously announced underwritten public offering of 50 million shares of its common stock and accompanying two-year warrants to purchase an aggregate of up to 50 million…
Comments Off on Evofem Biosciences Announces Closing of $50 Million Public Offering